Loading...

Supreme Cannabis Company

TSX:FIRE
Snowflake Description

High growth potential with adequate balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
FIRE
TSX
CA$456M
Market Cap
  1. Home
  2. CA
  3. Pharmaceuticals & Biotech
Company description

The Supreme Cannabis Company, Inc. engages in the production of medical cannabis in Canada. The last earnings update was 36 days ago. More info.


Add to Portfolio Compare Print
  • Supreme Cannabis Company has significant price volatility in the past 3 months.
FIRE Share Price and Events
7 Day Returns
-13.4%
TSX:FIRE
-6.3%
CA Pharmaceuticals
0%
CA Market
1 Year Returns
-3.1%
TSX:FIRE
-4.9%
CA Pharmaceuticals
-3.1%
CA Market
FIRE Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Supreme Cannabis Company (FIRE) -13.4% -16.7% -30.2% -3.1% - -
CA Pharmaceuticals -6.3% -14.7% -20.8% -4.9% 624.1% 428.2%
CA Market 0% -1.3% -1% -3.1% 11.3% 0.9%
1 Year Return vs Industry and Market
  • FIRE outperformed the Pharmaceuticals industry which returned -4.9% over the past year.
Price Volatility
FIRE
Industry
5yr Volatility vs Market

FIRE Value

 Is Supreme Cannabis Company undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Supreme Cannabis Company. This is due to cash flow or dividend data being unavailable. The share price is CA$1.55.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Supreme Cannabis Company's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Supreme Cannabis Company's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSX:FIRE PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-03-31) in CAD CA$-0.05
TSX:FIRE Share Price ** TSX (2019-06-17) in CAD CA$1.55
Canada Pharmaceuticals Industry PE Ratio Median Figure of 11 Publicly-Listed Pharmaceuticals Companies 20.76x
Canada Market PE Ratio Median Figure of 545 Publicly-Listed Companies 15.07x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Supreme Cannabis Company.

TSX:FIRE PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:FIRE Share Price ÷ EPS (both in CAD)

= 1.55 ÷ -0.05

-30.36x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Supreme Cannabis Company is loss making, we can't compare its value to the CA Pharmaceuticals industry average.
  • Supreme Cannabis Company is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Supreme Cannabis Company's expected growth come at a high price?
Raw Data
TSX:FIRE PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -30.36x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts
129.6%per year
Canada Pharmaceuticals Industry PEG Ratio Median Figure of 7 Publicly-Listed Pharmaceuticals Companies 1.16x
Canada Market PEG Ratio Median Figure of 247 Publicly-Listed Companies 1.15x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Supreme Cannabis Company, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Supreme Cannabis Company's assets?
Raw Data
TSX:FIRE PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-03-31) in CAD CA$0.70
TSX:FIRE Share Price * TSX (2019-06-17) in CAD CA$1.55
Canada Pharmaceuticals Industry PB Ratio Median Figure of 145 Publicly-Listed Pharmaceuticals Companies 2.72x
Canada Market PB Ratio Median Figure of 2,414 Publicly-Listed Companies 1.41x
TSX:FIRE PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:FIRE Share Price ÷ Book Value per Share (both in CAD)

= 1.55 ÷ 0.70

2.21x

* Primary Listing of Supreme Cannabis Company.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Supreme Cannabis Company is good value based on assets compared to the CA Pharmaceuticals industry average.
X
Value checks
We assess Supreme Cannabis Company's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Pharmaceuticals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Pharmaceuticals industry average (and greater than 0)? (1 check)
  5. Supreme Cannabis Company has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

FIRE Future Performance

 How is Supreme Cannabis Company expected to perform in the next 1 to 3 years based on estimates from 7 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
129.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Supreme Cannabis Company expected to grow at an attractive rate?
  • Supreme Cannabis Company's earnings growth is expected to exceed the low risk savings rate of 1.9%.
Growth vs Market Checks
  • Supreme Cannabis Company's earnings growth is expected to exceed the Canada market average.
  • Supreme Cannabis Company's revenue growth is expected to exceed the Canada market average.
Annual Growth Rates Comparison
Raw Data
TSX:FIRE Future Growth Rates Data Sources
Data Point Source Value (per year)
TSX:FIRE Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 7 Analysts 129.6%
TSX:FIRE Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 7 Analysts 81.9%
Canada Pharmaceuticals Industry Earnings Growth Rate Market Cap Weighted Average 89.2%
Canada Pharmaceuticals Industry Revenue Growth Rate Market Cap Weighted Average 54.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 14.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 5.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSX:FIRE Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSX:FIRE Future Estimates Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2021-06-30 184 -16 43 3
2020-06-30 130 -21 10 7
2019-06-30 36 -29 -19 7
TSX:FIRE Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-03-31 26 -10 -14
2018-12-31 18 -11 -10
2018-09-30 12 -6 -11
2018-06-30 9 1 -7
2018-03-31 5 -2 -4
2017-12-31 3 0 -4
2017-09-30 2 1 -14
2017-06-30 -3 -15
2017-03-31 -4 -20
2016-12-31 -3 -19
2016-09-30 -3 -7
2016-06-30 -2 -4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Supreme Cannabis Company's earnings are expected to grow significantly at over 20% yearly.
  • Supreme Cannabis Company's revenue is expected to grow significantly at over 20% yearly.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSX:FIRE Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below

All data from Supreme Cannabis Company Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:FIRE Future Estimates Data
Date (Data in CAD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2021-06-30 0.06 0.12 -0.01 2.00
2020-06-30 0.01 0.07 -0.07 4.00
2019-06-30 -0.06 -0.05 -0.08 4.00
TSX:FIRE Past Financials Data
Date (Data in CAD Millions) EPS *
2019-03-31 -0.05
2018-12-31 -0.04
2018-09-30 -0.04
2018-06-30 -0.03
2018-03-31 -0.02
2017-12-31 -0.02
2017-09-30 -0.08
2017-06-30 -0.09
2017-03-31 -0.14
2016-12-31 -0.14
2016-09-30 -0.06
2016-06-30 -0.05

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Supreme Cannabis Company will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Supreme Cannabis Company's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Supreme Cannabis Company has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

FIRE Past Performance

  How has Supreme Cannabis Company performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Supreme Cannabis Company's growth in the last year to its industry (Pharmaceuticals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Supreme Cannabis Company does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Supreme Cannabis Company's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Supreme Cannabis Company's 1-year growth to the CA Pharmaceuticals industry average as it is not currently profitable.
Earnings and Revenue History
Supreme Cannabis Company's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Supreme Cannabis Company Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:FIRE Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-03-31 26.37 -13.84 30.14
2018-12-31 18.47 -10.07 25.26
2018-09-30 12.43 -10.55 17.19
2018-06-30 8.85 -7.35 15.54
2018-03-31 5.31 -3.76 12.73
2017-12-31 3.24 -4.17 9.64
2017-09-30 1.56 -14.24 19.20
2017-06-30 -15.27 18.03
2017-03-31 -20.38 17.26
2016-12-31 -18.64 17.68
2016-09-30 -7.06 6.58
2016-06-30 -4.39 4.09
2016-03-31 -4.12 3.77
2015-12-31 -2.64 2.41
2015-09-30 -5.12 4.65
2015-06-30 -5.79 5.47
2015-03-31 -6.40 5.73
2014-12-31 -6.01 5.42
2014-09-30 -3.17 2.90
2014-06-30 -1.99 1.72
2014-03-31 -0.80 0.44
2013-12-31 -0.72 0.25
2013-09-30 -0.60 0.12
2013-06-30 -0.61 0.13
2013-03-31 -0.54 0.12
2012-12-31 -0.53 0.14
2012-09-30 -0.52 0.13
2012-06-30 -0.81 0.15

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Supreme Cannabis Company has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Supreme Cannabis Company has efficiently used its assets last year compared to the CA Pharmaceuticals industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Supreme Cannabis Company improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Supreme Cannabis Company's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Pharmaceuticals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Supreme Cannabis Company has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

FIRE Health

 How is Supreme Cannabis Company's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Supreme Cannabis Company's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Supreme Cannabis Company is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Supreme Cannabis Company's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Supreme Cannabis Company's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Supreme Cannabis Company Company Filings, last reported 2 months ago.

TSX:FIRE Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-03-31 205.04 75.50 75.02
2018-12-31 206.65 72.30 91.97
2018-09-30 147.91 31.12 31.20
2018-06-30 145.15 31.72 55.90
2018-03-31 142.38 30.37 78.50
2017-12-31 91.07 46.58 77.56
2017-09-30 61.98 30.92 51.90
2017-06-30 59.09 31.71 57.68
2017-03-31 48.46 39.59 67.28
2016-12-31 49.39 42.68 71.73
2016-09-30 33.04 4.00 16.45
2016-06-30 19.36 4.04 4.93
2016-03-31 16.44 4.03 2.75
2015-12-31 15.14 4.32 1.75
2015-09-30 13.95 4.31 0.63
2015-06-30 13.59 4.45 0.57
2015-03-31 13.03 3.61 0.11
2014-12-31 12.90 3.58 0.36
2014-09-30 12.38 3.54 1.57
2014-06-30 10.38 3.51 1.12
2014-03-31 -0.11 0.22 0.04
2013-12-31 0.05 0.06 0.07
2013-09-30 -0.17 0.12 0.00
2013-06-30 -0.15 0.05 0.00
2013-03-31 0.30 0.06 0.00
2012-12-31 0.36 0.07 0.00
2012-09-30 0.42 0.04 0.00
2012-06-30 0.45 0.03 0.00
  • Supreme Cannabis Company's level of debt (36.8%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (2534.5% vs 36.8% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • Supreme Cannabis Company has less than a year of cash runway based on current free cash flow.
  • Supreme Cannabis Company has less than a year of cash runway if free cash flow continues to grow at historical rates of 94.9% each year.
X
Financial health checks
We assess Supreme Cannabis Company's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Supreme Cannabis Company has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

FIRE Dividends

 What is Supreme Cannabis Company's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Supreme Cannabis Company dividends. Estimated to be 0% next year.
If you bought CA$2,000 of Supreme Cannabis Company shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Supreme Cannabis Company's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Supreme Cannabis Company's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSX:FIRE Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 7 Analyst Estimates (S&P Global) See Below
North America Pharmaceuticals Industry Average Dividend Yield Market Cap Weighted Average of 10 Stocks 2.7%
Canada Market Average Dividend Yield Market Cap Weighted Average of 335 Stocks 3.6%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

TSX:FIRE Future Dividends Estimate Data
Date (Data in CA$) Dividend per Share (annual) Avg. No. Analysts
2021-06-30
2020-06-30 0.00 1.00
2019-06-30 0.00 1.00

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Supreme Cannabis Company has not reported any payouts.
  • Unable to verify if Supreme Cannabis Company's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Supreme Cannabis Company's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Supreme Cannabis Company has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Supreme Cannabis Company's dividends in 3 years as they are not expected to pay a notable one for Canada.
X
Income/ dividend checks
We assess Supreme Cannabis Company's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Supreme Cannabis Company afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Supreme Cannabis Company has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

FIRE Management

 What is the CEO of Supreme Cannabis Company's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Navdeep Dhaliwal
COMPENSATION CA$4,387,788
TENURE AS CEO 0.8 years
CEO Bio

Mr. Navdeep Dhaliwal, CA, is a Co-Owner of 2551448 Ontario Inc. Mr. Dhaliwal serves as Chief Executive Officer at Supreme Pharmaceuticals Inc. since September 24, 2018. Mr. Dhaliwal continues to focus on executing on Supreme Pharmaceuticals’ broader global growth strategy including M&A opportunities, strategic investments, and developing its international and medical businesses. He also continues to lead the Company’s investor and capital markets relations activities. Mr. Dhaliwal served as President of Supreme Pharmaceuticals Inc. since October 19, 2017 until September 24, 2018 and served as its Chief Financial Officer from April 25, 2016 to October 19, 2017. Mr. Dhaliwal serves as the Principal of NLX Capital Corp., a Toronto-based corporate development firm focused primarily on technology and renewable energy. He retained by a Toronto software company, where he successfully expanded its business into South East Asia, where he has extensive business experience. He has been involved in the Canadian medical marijuana space for two years prior to joining Supreme. He has been a Director of Supreme Pharmaceuticals Inc. since November 16, 2015. Mr. Dhaliwal served a Director of BlissCo Cannabis Corp. from February 22, 2018 to September 2018. He is a Chartered Accountant.

CEO Compensation
  • Navdeep's compensation has increased whilst company is loss making.
  • Navdeep's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure of the Supreme Cannabis Company management team in years:

1.2
Average Tenure
  • The average tenure for the Supreme Cannabis Company management team is less than 2 years, this suggests a new team.
Management Team

Navdeep Dhaliwal

TITLE
CEO & Director
COMPENSATION
CA$4M
TENURE
0.8 yrs

John Fowler

TITLE
President
COMPENSATION
CA$4M
TENURE
0.8 yrs

Sony Gokhale

TITLE
General Counsel
COMPENSATION
CA$2M
TENURE
1.4 yrs

Scott Walters

TITLE
Vice President of Corporate Development
COMPENSATION
CA$36K
TENURE
0.6 yrs

Ramana Davloor

TITLE
General Manager of 7ACRES
COMPENSATION
CA$1M
TENURE
1.4 yrs

Nikhil Handa

TITLE
Chief Financial Officer
TENURE
0.2 yrs

Peter Herburger

TITLE
Director of Operations
TENURE
4.2 yrs

Chander Batra

TITLE
Chief Information Officer
TENURE
1.3 yrs

Steve Chan

TITLE
VP of Stakeholder Relations & Corporate Secretary
TENURE
1 yrs

Omer Azeez

TITLE
Vice President of Marketing
TENURE
1.8 yrs
Board of Directors Tenure

Average tenure and age of the Supreme Cannabis Company board of directors in years:

3.6
Average Tenure
59
Average Age
  • The tenure for the Supreme Cannabis Company board of directors is about average.
Board of Directors

Michael La Brier

TITLE
Chairman
COMPENSATION
CA$473K
AGE
68
TENURE
3.2 yrs

Navdeep Dhaliwal

TITLE
CEO & Director
COMPENSATION
CA$4M
TENURE
3.6 yrs

John Fowler

TITLE
President
COMPENSATION
CA$4M
TENURE
4.5 yrs

Ron Factor

TITLE
Director
COMPENSATION
CA$222K
TENURE
2.1 yrs

Colin Moore

TITLE
Independent Director
COMPENSATION
CA$331K
TENURE
0.1 yrs

Davis Stadnyk

TITLE
Member of Advisory Board
COMPENSATION
CA$240K
AGE
55
TENURE
4.6 yrs

Chris Bechtel

TITLE
Member of Advisory Board
COMPENSATION
CA$317K
AGE
59
TENURE
4.8 yrs

Youbin Zheng

TITLE
Member of Advisory Board
TENURE
4.5 yrs

Ken McKinnon

TITLE
Independent Director
AGE
59
TENURE
0.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
11. Mar 19 Sell Cailin Ghelsen Individual 07. Mar 19 07. Mar 19 -20,000 CA$2.08 CA$-41,600
19. Feb 19 Buy Barinder Bhullar Individual 14. Feb 19 14. Feb 19 6,587 CA$1.83 CA$12,054
28. Jan 19 Buy Omer Azeez Individual 22. Jan 19 22. Jan 19 14,405 CA$1.70 CA$24,489
28. Jan 19 Buy Scott Walters Individual 23. Jan 19 23. Jan 19 5,000 CA$1.72 CA$8,600
28. Jan 19 Buy Steve Chan Individual 24. Jan 19 24. Jan 19 43,300 CA$1.72 CA$74,476
25. Jan 19 Buy Michael La Brier Individual 25. Jan 19 25. Jan 19 61,000 CA$1.75 CA$106,750
24. Jan 19 Buy Sunpreet Gokhale Individual 23. Jan 19 24. Jan 19 25,684 CA$1.73 CA$44,213
23. Jan 19 Buy Craig Young Individual 23. Oct 18 21. Jan 19 20,500 CA$1.75 CA$34,634
22. Jan 19 Buy Chander Batra Individual 22. Jan 19 22. Jan 19 11,000 CA$1.75 CA$19,250
17. Jan 19 Buy Dimitre Naoumov Individual 15. Jan 19 15. Jan 19 21,750 CA$1.78 CA$38,715
17. Jan 19 Buy John Fowler Individual 15. Jan 19 15. Jan 19 71,855 CA$1.81 CA$130,000
16. Jan 19 Buy Navdeep Dhaliwal Individual 14. Jan 19 14. Jan 19 78,280 CA$1.74 CA$136,121
26. Oct 18 Buy Ramana Davloor Individual 22. Oct 18 22. Oct 18 3,225 CA$1.54 CA$4,967
23. Oct 18 Buy Chander Batra Individual 19. Oct 18 23. Oct 18 20,000 CA$1.96 CA$35,071
23. Oct 18 Buy Dimitre Naoumov Individual 22. Oct 18 22. Oct 18 15,000 CA$1.63 CA$24,450
X
Management checks
We assess Supreme Cannabis Company's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Supreme Cannabis Company has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

FIRE News

Simply Wall St News

The Supreme Cannabis Company (TSE:FIRE) Share Price Is Up 508% And Shareholders Are Delighted

View our latest analysis for Supreme Cannabis Company Because Supreme Cannabis Company is loss-making, we think the market is probably more focussed on revenue and revenue growth, at least for now. … This free report showing analyst forecasts should help you form a view on Supreme Cannabis Company A Different Perspective While the broader market gained around 0.4% in the last year, Supreme Cannabis Company shareholders lost 7.9%. … Supreme Cannabis Company is not the only stock that insiders are buying.

Simply Wall St -

FIRE Company Info

Description

The Supreme Cannabis Company, Inc. engages in the production of medical cannabis in Canada. The company was formerly known as Supreme Pharmaceuticals Inc. and changed its name to The Supreme Cannabis Company, Inc. in December 2017. The Supreme Cannabis Company, Inc. was incorporated in 1979 and is headquartered in Toronto, Canada.

Details
Name: The Supreme Cannabis Company, Inc.
FIRE
Exchange: TSX
Founded: 1979
CA$455,856,131
294,100,730
Website: http://www.supreme.ca
Address: The Supreme Cannabis Company, Inc.
178R Ossington Avenue,
Toronto,
Ontario, M6J 2Z7,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX FIRE Common Shares The Toronto Stock Exchange CA CAD 11. Jan 2006
OTCPK SPRW.F Common Shares Pink Sheets LLC US USD 11. Jan 2006
DB 53S1 Common Shares Deutsche Boerse AG DE EUR 11. Jan 2006
Number of employees
Current staff
Staff numbers
270
Supreme Cannabis Company employees.
Industry
Pharmaceuticals
Pharmaceuticals & Biotech
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/06/18 00:15
End of day share price update: 2019/06/17 00:00
Last estimates confirmation: 2019/06/03
Last earnings filing: 2019/05/13
Last earnings reported: 2019/03/31
Last annual earnings reported: 2018/06/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.